menu
    • menu

    Company profile for Antios Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its lead oral drug candidate for a potentially curative treatment of HBV infections.Founded in 2018, Antios Therapeutics is a biopharmaceutical company focused on the development of innovative therapies to treat and cure vi...
    Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its lead oral drug candidate for a potentially curative treatment of HBV infections.Founded in 2018, Antios Therapeutics is a biopharmaceutical company focused on the development of innovative therapies to treat and cure viral diseases Our lead therapeutic candidate, ATI-2173, is a first-in-class Active Site Polymerase Inhibitor Nucleotide (ASPIN) that is in clinical development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Antios TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Atlanta, Georgia 30355
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.antiostherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/antios/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AntiosTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hep B biotech Antios closed after FDA hold proved insurmountable
    Hep B biotech Antios closed after FDA hold proved insurmountable

    22 Sep 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/hep-b-biotech-antios-closed-after-fda-hold-proved-insurmountable

    Annalee Armstrong FIERCE BIOTECH
    22 Sep 2023
    Share Share
    Antios hep B drug slows viral rebound, but FDA hold casts shadow
    Antios hep B drug slows viral rebound, but FDA hold casts shadow

    27 Jun 2022

    // Annalee Armstrong FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/antios-therapy-could-be-bridge-hep-b-treatment-first-fda-hold-resolve

    Annalee Armstrong FIERCEBIOTECH
    27 Jun 2022
    Share Share
    Antios' ATI-2173 Demonstrates Suppression of Hepatitis B Virus in PIIa Study
    Antios' ATI-2173 Demonstrates Suppression of Hepatitis B Virus in PIIa Study

    25 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/antios-therapeutics-ati-2173-demonstrates-suppression-of-hepatitis-b-virus-in-phase-2a-study-ati-1428-and-ati-1645-exhibit-potent-antiviral-activity-in-a-nonclinical-study-301574996.html

    PRNEWSWIRE
    25 Jun 2022
    Share Share
    Antios Announces Oral Presentations on three Hepatitis B Virus Programs
    Antios Announces Oral Presentations on three Hepatitis B Virus Programs

    08 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/antios-therapeutics-announces-oral-presentations-on-ati-2173-ati-1428-and-ati-1645-hepatitis-b-virus-programs-at-the-easl-international-liver-congress-2022-301563419.html

    PRNEWSWIRE
    08 Jun 2022
    Share Share
    FDA Puts Clinical Hold on Antios' HBV Therapy, Ends Collaboration with Assembly
    FDA Puts Clinical Hold on Antios' HBV Therapy, Ends Collaboration with Assembly

    01 Jun 2022

    // TRIALSITENEWS

    https://www.trialsitenews.com/a/fda-places-clinical-hold-on-antios-hbv-therapy-ending-collaboration-with-assembly-af132372

    TRIALSITENEWS
    01 Jun 2022
    Share Share
    Heart trouble report & clinical hold spell end of Antios, Assembly Bio alliance
    Heart trouble report & clinical hold spell end of Antios, Assembly Bio alliance

    26 May 2022

    // F. Vinluan MEDCITYNEWS

    https://medcitynews.com/2022/05/heart-trouble-report-clinical-hold-spell-end-of-antios-assembly-bio-hbv-alliance/

    F. Vinluan MEDCITYNEWS
    26 May 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search